Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC.ACHV · Entity 5072 | President & CMO | September 04, 2025 | September 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACHIEVE LIFE SCIENCES, INC.
Report date September 04, 2025 · Filed September 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,585 |
Ending reported balance
After 2025-09-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-04 · Exercise / conversion · Acquired 110,000 · Balance 143,214 F1: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Row 2 · 2025-09-04 · Sale · Disposed 27,629 · Balance 115,585 F2: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Performance Restricted Stock Unit (PRSU)SEC Table II · derivative / convertible security · Expires 2028-01-22 | Direct | 0 |
Reported balance
After 2025-09-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-09-04 · Exercise / conversion · Disposed 84,000 · Balance 0 F4: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F6: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
| Performance Restricted Stock Unit (PRSU)SEC Table II · derivative / convertible security · Expires 2035-01-28 | Direct | 104,000 |
Reported balance
After 2025-09-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-09-04 · Exercise / conversion · Disposed 26,000 · Balance 104,000 F7: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F8: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
F2: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs.
F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F5: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F6: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.
F7: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F8: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2018 Filed Aug 15, 2019 21:15 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046194 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 19:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001209191-18-044358 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-07-26 F1 · derivative.exercise_date: The options vest in monthly installments over 48 months commencing one month from July 26 2018. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:01 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 274,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001209191-17-047599 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,000 Underlying: Common Stock · 274,000 shares Expires 2027-08-01 F5 · derivative.exercise_date: The options vest as to 25% on August 1, 2018 and thereafter in monthly installments over 36 months. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 01:01 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantRestricted Stock Unit (RSU) · Derivative | 54,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047599 · doc4.xml · derivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,800 Underlying: Common Stock · 54,800 shares Expires 2021-08-01 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F3 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. F4 · derivative.expiration_date: The RSUs expire 30 days from the date they vest. Read SEC document |
| August 01, 2017 Filed Sep 12, 2017 18:52 UTC Amendment | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 274,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-17-052380 · doc4a.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,000 Underlying: Common Stock · 274,000 shares Expires 2027-08-01 F1 · derivative.exercise_price: This amended Form 4 is filed to correct the exercise price to reflect that the grant was effective as of the issuer's first open trading window after approval of the grant. All other terms remain the same. F2 · derivative.exercise_date: The options vest as to 25% on August 1, 2018 and thereafter in monthly installments over 36 months. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:30 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039835 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually each anniversary of June 12, 2014, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:30 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Tax withholdingCommon Stock | 1,633 | $0.36 | $587.88 |
DisclosureSEC source: 0001209191-17-039835 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,726 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs and does not represent a sale by the reporting person. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:30 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039835 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:48 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003464 · doc4.xml · derivative · entry 5 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 4,687 shares Expires 2019-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:48 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003464 · doc4.xml · derivative · entry 4 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Common Stock · 3,125 shares Expires 2018-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:48 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003464 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:48 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Tax withholdingCommon Stock | 3,369 | $0.63 | $2,122.47 |
DisclosureSEC source: 0001209191-17-003464 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,359 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:48 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 10,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003464 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.